CUV 0.00% $14.30 clinuvel pharmaceuticals limited

News: CUV UPDATE 1-U.S. FDA approves Clinuvel Pharma's rare genetic disorder treatment, page-121

  1. 103 Posts.
    lightbulb Created with Sketch. 4
    A good sign. The fund hasn't exactly knocked it out of the park though...2.39% p.a over 5 years. Let's hope they've picked the right stock
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.